Answers are grounded in this paper and cite their sources.
This research summarizes the impact of the major comorbidities impacting hospitalized women with COVID-19 and their relation to death. Public data from national databases (2020-2022) for hospitalized women, including identification data, hospitalization time, comorbidities, and ICU admissions, were analyzed. Women were stratified by age (split at 50 years). Binary regression models determined the correlation between comorbidities and COVID-19 with mortality, expressed as odds ratios. 46,492 women were hospitalized, with 70.1% aged above 50 years old. 17,728 fatalities occurred, 86.5% in the older age group. 5.82% required intensive care. Common comorbidities: pneumonia, hypertension, diabetes, obesity, and intubation. 56.6% died within the first week; in ICU wards, 65.7% by week two. Logistic regression: diabetes, CKD initially significant, followed by pneumonia and CKD (days 8 -14), intubation and, ICU stay (beyond 15th day). In ICU wards, intubation impact worsened over time. Our study highlights comorbidities' significant impact on COVID-19 mortality among women in Valley of Mexico. Pneumonia, diabetes, CKD, and intubation were notably prevalent and correlated strongly with death in older women. Timely intubation improves survival, while delayed intubation increases mortality risk, particularly in ICU. Urgent targeted interventions are required, especially for older hospitalized women.
No takes yet. Share an insight, caveat, or question.
Chao et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: